Wednesday, March 12, 2014 9:33:37 AM
Again I've played these many times. A company does not put up 10 million dollars in a hope that they break even on the initial investment. Then years down the road they finally make a profit on options. These investment companies have quarterly reports and earnings goals they have to meet. They would be fired if they were not making money for 5 years.
I've played these before and what ends up happening is that the .25 becomes the floor. It might take a few weeks for that floor to get established but they almost always do. The company will supply support at their buy price trying to keep the stock price up.
We will just have to watch what happens over the next few weeks. I am only in this trade for 15% to 20% gain.
On the other hand this stock will skyrocket this year based on the DD I have done. It has a lot of eyes on it.
I've played these before and what ends up happening is that the .25 becomes the floor. It might take a few weeks for that floor to get established but they almost always do. The company will supply support at their buy price trying to keep the stock price up.
We will just have to watch what happens over the next few weeks. I am only in this trade for 15% to 20% gain.
On the other hand this stock will skyrocket this year based on the DD I have done. It has a lot of eyes on it.
Email: sheepery@gmail.com
Recent CTSO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:21:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:05:35 PM
- CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update • PR Newswire (US) • 05/13/2026 08:00:00 PM
- CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights • PR Newswire (US) • 04/30/2026 11:00:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/15/2026 09:18:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 11:00:20 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 11:04:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:27:51 PM
- CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/25/2026 08:05:00 PM
- CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026 • PR Newswire (US) • 03/19/2026 01:44:00 PM
- CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/05/2026 12:00:00 PM
- CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update • PR Newswire (US) • 01/12/2026 12:00:00 PM
- CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 • PR Newswire (US) • 12/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 02:09:45 AM
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London • PR Newswire (US) • 11/17/2025 10:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:34:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:32:19 PM
- CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update • PR Newswire (US) • 11/13/2025 09:05:00 PM
- CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London • PR Newswire (US) • 11/11/2025 12:00:00 PM
- CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 10/30/2025 11:00:00 AM
- In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer • PR Newswire (US) • 10/28/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 08:20:54 PM
- CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen • PR Newswire (US) • 09/29/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 08:35:38 PM
- CytoSorbents Provides DrugSorb-ATR Regulatory Update • PR Newswire (US) • 09/16/2025 11:00:00 AM
